Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Aquaporins01:25

Aquaporins

6.7K
Aquaporins or AQPs are a family of integral membrane proteins whose primary function is to transport water, while some called aquaglyceroporins also transport glycerol. In addition, aquaporins have also been suspected to be involved in transporting volatile substances, such as carbon dioxide and ammonia, across membranes. Such AQPs that act as gas channels are often highly expressed in cells involved in the gaseous exchange, such as red blood cells, epithelial cells, and pulmonary capillaries.
6.7K
Regulation of Water Intake01:25

Regulation of Water Intake

2.9K
Osmolality refers to the number of solute particles per kilogram of solvent in a solution. Plasma osmolality specifically indicates the total number of solute particles per kilogram of water in blood plasma. This value reflects the body's hydration status and is tightly regulated through mechanisms controlling water intake and output. While water consumption is a conscious decision, the body has intrinsic regulatory systems to maintain fluid balance. Dehydration, a state of water deficit...
2.9K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

331
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
331
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

320
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
320
Reabsorption and Secretion in the DCT and Collecting Duct01:26

Reabsorption and Secretion in the DCT and Collecting Duct

3.7K
The early phase of the DCT manages the reabsorption of approximately 10-15% of filtered water, 5–10% of filtered sodium, and 5–10% of filtered chloride. This process is facilitated by Na+–Cl− symporters in apical membranes and sodium-potassium pumps, as well as Cl− leakage channels in basolateral membranes. The early DCT also stands out as a site where parathyroid hormone (PTH) stimulates calcium reabsorption, depending on the body's requirements.
The distal...
3.7K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

259
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
259

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cork oak aquaporins: functional diversity and regulation with insights into drought response.

Plant cell reports·2026
Same author

Aquaporin-3 and aquaporin-5 impact the development of pancreatic ductal adenocarcinoma spheroids.

FEBS open bio·2026
Same author

The relevance of considering metal-ligand speciation in aquaporin modulation by cu, Zn, and V complexes with 1,10-phenanthroline ligands.

Journal of inorganic biochemistry·2026
Same author

Aquaporin-1, aquaporin-3 and aquaporin-5 differentially modulate cell biophysical and biomechanical properties, impacting cell stiffness and cell-cell adhesion.

The FEBS journal·2025
Same author

The Association of Aquaporins with MAPK Signaling Pathway Unveils Potential Prognostic Biomarkers for Pancreatic Cancer: A Transcriptomics Approach.

Biomolecules·2025
Same author

Editorial: In celebration of women in science: cellular biochemistry.

Frontiers in molecular biosciences·2025

Related Experiment Video

Updated: Mar 6, 2026

Tracking Single Proteins in Lipid Bilayers Using Fluorescence Microscopy
08:39

Tracking Single Proteins in Lipid Bilayers Using Fluorescence Microscopy

Published on: December 12, 2025

822

Aquaporins in Obesity.

Inês Vieira da Silva1,2, Graça Soveral3,4

  • 1Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, 1649-003, Portugal.

Advances in Experimental Medicine and Biology
|March 5, 2017
PubMed
Summary

Aquaporins, particularly AQP7 in adipose tissue, are key to glycerol metabolism and energy balance. Targeting these channels may offer a new strategy for managing obesity and related metabolic disorders.

Keywords:
AdiposeAquaglyceroporinGlycerol

More Related Videos

Culturing Primary Rat Inner Medullary Collecting Duct Cells
06:11

Culturing Primary Rat Inner Medullary Collecting Duct Cells

Published on: June 21, 2013

15.3K
Studying the Activity of Neuropeptides and Other Regulators of the Excretory System in the Adult Mosquito
11:30

Studying the Activity of Neuropeptides and Other Regulators of the Excretory System in the Adult Mosquito

Published on: August 24, 2021

3.4K

Related Experiment Videos

Last Updated: Mar 6, 2026

Tracking Single Proteins in Lipid Bilayers Using Fluorescence Microscopy
08:39

Tracking Single Proteins in Lipid Bilayers Using Fluorescence Microscopy

Published on: December 12, 2025

822
Culturing Primary Rat Inner Medullary Collecting Duct Cells
06:11

Culturing Primary Rat Inner Medullary Collecting Duct Cells

Published on: June 21, 2013

15.3K
Studying the Activity of Neuropeptides and Other Regulators of the Excretory System in the Adult Mosquito
11:30

Studying the Activity of Neuropeptides and Other Regulators of the Excretory System in the Adult Mosquito

Published on: August 24, 2021

3.4K

Area of Science:

  • Biochemistry
  • Physiology
  • Molecular Biology

Background:

  • Obesity is a major metabolic disorder linked to cardiovascular risks like insulin resistance, diabetes, dyslipidemia, and hypertension (Metabolic Syndrome).
  • Aquaporins (water channels) play a crucial role in glycerol transport, impacting lipid balance and energy homeostasis.
  • Dysregulation of aquaporins is implicated in obesity and insulin resistance.

Purpose of the Study:

  • To review the physiological role of aquaglyceroporins in glycerol metabolism and lipid homeostasis.
  • To highlight their tissue distribution and involvement in obesity and metabolic complications.
  • To explore the therapeutic potential of targeting aquaglyceroporins for metabolic disorders.

Main Methods:

  • Literature review of studies on aquaporins, glycerol metabolism, and obesity.
  • Analysis of aquaglyceroporins' tissue-specific expression and function.
  • Examination of their role in energy balance and fat metabolism.

Main Results:

  • Aquaglyceroporins facilitate glycerol release from adipose tissue and distribution.
  • Their function is critical for maintaining lipid balance and energy homeostasis.
  • Specific aquaporins, like AQP7 in adipose tissue, are implicated in obesity and metabolic dysfunction.

Conclusions:

  • Aquaglyceroporins are vital regulators of glycerol metabolism and lipid homeostasis.
  • Targeting aquaglyceroporins, especially AQP7, presents a potential novel therapeutic avenue for obesity and metabolic disorders.
  • Further research into pharmacologic modulators of aquaglyceroporins is warranted.